Researchers from Harvard University are experimenting with a new vaccine implant to train the immune system to fight tumors, particularly deadly melanomas killing thousands of Americans every year. The clinical trials...
Modified dendritic cells that can recognize cancer-made protein fragments have shown promise in a small clinical trial studying melanoma. Duke University’s Scott Pruitt, M.D., Ph.D., also of Merck Research Laboratories...